ArticleJournal of diabetes research2026

Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial.

Xiaohui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.